Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies

Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies

Glioblastoma multiforme (GBM) is the most common and malignant of the glial tumors. The world-wide estimates of new cases and deaths annually are remarkable, making GBM a crucial public health issue. Despite the combination of radical surgery, radio and chemotherapy prognosis is extremely poor (medi...

Full description

Bibliographic Details
Main Authors: Marta Cenciarini, Mario Valentino, Silvia Belia, Luigi Sforna, Paolo Rosa, Simona Ronchetti, Maria Cristina D’Adamo, Mauro Pessia
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Molecular Neuroscience
Subjects:
GBM
dexamethasone
cerebral oedema
pharmacogenomics
glioblastoma multiforme therapy
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2019.00065/full

Internet

https://www.frontiersin.org/article/10.3389/fnmol.2019.00065/full

Similar Items